118th Congress · SENATE BILLBILL

S. 2329 — Emerging Pathogen Preparedness Program Authorization Act

“A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.”

Health

Introduced Jul 13, 2023

Last action Jul 13, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jul 13, 2023

Step 2

Referred

Jul 13, 2023

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Jul 13, 2023

Introduced in Senate

Jul 13, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.